AI Meets Biotech is Germany's Next Innovation Wave
The convergence of biotechnology and artificial intelligence (AI4Bio) is injecting fresh momentum into Germany's life sciences sector. The country is emerging as an international hub for AI-driven drug discovery, next-generation mRNA innovation and pathology foundation models – and that’s attracting the interest of international companies.